Cihanbeylerden, M. Et Al. 2024. Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria. ALLERGY .

Cihanbeylerden, M., Teixeira, J., Kayikci, H., Tuccar, C., Kalyoncu, A. F., Damadoglu, E., ... Goncalo, M.(2024). Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria. ALLERGY .

Cihanbeylerden, MELEK Et Al. "Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria," ALLERGY , 2024

Cihanbeylerden, MELEK Et Al. "Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria." ALLERGY , 2024

Cihanbeylerden, M. Et Al. (2024) . "Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria." ALLERGY .

@article{article, author={MELEK CİHANBEYLERDEN Et Al. }, title={Assessing Risk Factors for Relapse Following Omalizumab Discontinuation in Chronic Urticaria}, journal={ALLERGY}, year=2024}